Market Tracker

09/02 6:05pm ET

Geron Corp (NASDAQ:GERN)

2.39
Data as of Sep 02
 +0.01 / +0.42%
Today’s Change
1.31
Today|||52-Week Range
7.36
-46.64%
Year-to-Date

Today’s Trading

Previous close2.38
Today’s open2.41
Day’s range2.35 - 2.43
Volume2,444,754
Average volume (3 months)4,035,238
Market cap$373.5M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+24.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.07-0.56%
AMAGAMAG Pharmaceuticals...+0.13+0.57%
OXFDOxford Immunotec Glo...+1.31+9.32%
TRIBTrinity Biotech PLC-0.06-0.28%
Data as of 3:59pm ET, 09/02/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts